Plasmodium vivax is geographically the most widely distributed cause of malaria in people,
with up to 2· 5 billion people at risk and an estimated 80 million to 300 million clinical cases …

Primaquine is the only available drug for preventing relapse of malaria, and confusion
surrounds its use. This review examines the wide range of clinical applications of …

Background Malaria remains a problem for many countries classified as malaria free
through cases imported from endemic regions. Imported cases to non-endemic countries …

Background. Fever is a marker of potentially serious illness in returned travelers. Information
about causes of fever, organized by geographic area and traveler characteristics, can …

Primaquine phosphate has been used for preventing relapse of Plasmodium vivax and P.
ovale malaria since the early 1950s, based on its ability to kill latent (hypnozoite) and …

Malaria is caused by infection with protozoan parasites of the Plasmodium genus,
transmitted to humans by female anopheline mosquitoes. Plasmodia have adapted to a …

Practice of Travel Medicine: Guidelines by the Infectious Diseases Society of America | Clinical
Infectious Diseases | Oxford Academic Skip to Main Content Advertisement Oxford Academic …

Plasmodium vivax infects 130–435 million of the 2.6 billion people living at risk of infection.
Recent studies suggest that vivax malaria can become lethal in a similar way to severe …

Abstract Background Although the Asia Pacific region is the focus of the fastest-growing
tourist and travel industry, few data are available on the knowledge, attitudes and practices …

Background. Malaria is a common and important infection in travelers. Methods. We have
examined data reported to the GeoSentinel surveillance network to highlight characteristics …